Results 191 to 200 of about 79,890 (335)

Evaluating the optimal duration of medication treatment for opioid use disorder

Addiction, EarlyView.
Abstract Background and aims Clinicians have little guidance on the ideal length of time patients should remain on medication treatment for opioid use disorder (MOUD) before being able to safely discontinue MOUD. This study estimated how the risk of all‐cause mortality changes with the duration of MOUD, controlling for patient characteristics that ...
Corey J. Hayes, Rebecca A. Raciborski, Mahip Acharya, Nahiyan Bin Noor, Edward V. Nunes, T. John Winhusen   +5 more
wiley   +1 more source

Characteristics of methamphetamine‐related deaths in the United Kingdom, 1997–2024

Addiction, EarlyView.
Abstract Background and aims People who use methamphetamine have a standardised mortality ratio 6.8 times greater than the general population, with several countries reporting concerning increases in methamphetamine‐related mortality over the past decade.
Emmert Roberts, Rebecca McKetin, Caroline Copeland   +2 more
wiley   +1 more source

Reducing risk for illicit drug use and prescription drug misuse: High school gay-straight alliances and lesbian, gay, bisexual, and transgender youth

, 2014
Nicholas C. Heck, Nicholas A. Livingston, Annesa Flentje, Kathryn M. Oost, Brandon T. Stewart, Bryan N. Cochran   +5 more
openalex   +1 more source

Contingency management interventions for substance use and addictive behaviours: Review of the United Kingdom evidence base

Addiction, EarlyView.
Abstract Background and aims Substance use and other addictive behaviours including gambling remain major public health concerns in the UK. Despite the effectiveness of substance use treatment approaches, treatment adherence and success rates remain low.
Carol‐Ann Getty, Tricia McQuarrie, Eileen Brobbin   +2 more
wiley   +1 more source

Prevalence and Correlates of Prescription Drug Misuse Among a Racially Diverse Sample of Young Sexual Minority Men

, 2018
Dennis H. Li, Brian Mustanski
openalex   +2 more sources

Secondary analysis of a combined harm‐reduction treatment and extended‐release naltrexone randomized clinical trial for alcohol use disorder: Differences across race, ethnicity and sex assigned at birth

Addiction, EarlyView.
Abstract Background and Aims In a prior randomized clinical trial (RCT), combined pharmacobehavioral harm‐reduction treatment improved alcohol outcomes and physical health‐related quality of life (PH‐QoL). In this secondary analysis, we tested race, ethnicity and sex assigned at birth as predictors and moderators of these effects.
Silvi C. Goldstein, Nicole H. Weiss, Manshu Yang, Sarah W. Feldstein Ewing, Susan E. Collins   +4 more
wiley   +1 more source

Prescription drug misuse and risk factors among Somali adolescents: a qualitative study exploring peer influence, stress, and academic pressure. [PDF]

BMC Psychiatry
Jayte M, Mohamed AA, Karshe AH, Ali HO, Ahmed AH.   +4 more
europepmc   +1 more source

Prescription drug misuse, other substance use, and sexual identity: The significance of educational status and psychological distress in US young adults. [PDF]

Subst Abus, 2021
Klare DL, McCabe SE, Ford JA, Schepis TS.   +3 more
europepmc   +1 more source

Psychoactive prescription drug use disorders, misuse and abuse : Pharmacoepidemiological aspects

, 2016
Micaela Tjäderborn
openalex   +2 more sources

Estimating thresholds for risk of cannabis use disorder using standard delta‐9‐tetrahydrocannabinol (THC) units

Addiction, EarlyView.
Abstract Background and aims Lower risk guidelines for safer levels of cannabis use could help to reduce the health burden posed by cannabis use disorder (CUD). We aimed to estimate risk thresholds for CUD based on delta‐9‐tetrahydrocannabinol (THC) consumption using standard THC units (1 unit = 5 mg THC).
Rachel Lees Thorne, Will Lawn, Kat Petrilli, Katie Trinci, Anya Borissova, Shelan Ofori, Claire Mokrysz, H. Valerie Curran, Lindsey A. Hines, Tom P. Freeman   +9 more
wiley   +1 more source